|
ABOUT COMPANY
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.
|
EARNINGS
Gross Profit (TTM): 84228000
Market Capitalization: 1839841000
Operating Margin (TTM): 0.0019
PE Ratio: 7860
PEG Ratio: 0
Profit Margin: 0.0014
Revenue Per Share (TTM): 3.333
Revenue (TTM): 153822000
Quarterly Earnings Growth YOY: 0.244
Quarterly Revenue Growth YOY: 0.07
Trailing PE: 7860
|
DIVIDENDS
Diluted EPS (TTM): 0.005
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 3113000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|